BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35542)

  • 1. Effect of 6-azauridine on de novo pyrimidine biosynthesis in cultured Ehrlich ascites cells. Orotate inhibition of dihydroorotase and dihydroorotate dehydrogenase.
    Chen JJ; Jones ME
    J Biol Chem; 1979 Jun; 254(11):4908-14. PubMed ID: 35542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of pH and inhibitors upon the catalytic activity of the dihydroorotase of multienzymatic protein pyr1-3 from mouse Ehrlich ascites carcinoma.
    Christopherson RI; Jones ME
    J Biol Chem; 1980 Apr; 255(8):3358-70. PubMed ID: 6102565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum.
    Seymour KK; Lyons SD; Phillips L; Rieckmann KH; Christopherson RI
    Biochemistry; 1994 May; 33(17):5268-74. PubMed ID: 7909690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390).
    Peters GJ; Sharma SL; Laurensse E; Pinedo HM
    Invest New Drugs; 1987; 5(3):235-44. PubMed ID: 2822596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation by 6-azauridine of carbamoyl phosphate synthesis for pyrimidine biosynthesis in mouse spleen slices.
    Tatibana M; Kita K; Asai T
    Eur J Biochem; 1982 Nov; 128(2-3):625-9. PubMed ID: 6185334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimidine biosynthesis and its regulation in embryos of the sea urchin, Arbacia punctulata.
    Crandall DE; Tremblay GC
    Comp Biochem Physiol B; 1976; 55(4):571-81. PubMed ID: 11941
    [No Abstract]   [Full Text] [Related]  

  • 7. Human spleen dihydroorotate dehydrogenase: a study of inhibition of the enzyme.
    Gero AM; O'Sullivan WJ; Brown DJ
    Biochem Med; 1985 Aug; 34(1):60-9. PubMed ID: 2996510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase.
    Krungkrai J; Krungkrai SR; Phakanont K
    Biochem Pharmacol; 1992 Mar; 43(6):1295-301. PubMed ID: 1348618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymes of de novo pyrimidine biosynthesis in Babesia rodhaini.
    Holland JW; Gero AM; O'Sullivan WJ
    J Protozool; 1983 Feb; 30(1):36-40. PubMed ID: 6134826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of pyrimidines as dihydroorotate dehydrogenase inhibitors.
    DeFrees SA; Sawick DP; Cunningham B; Heinstein PF; Morré DJ; Cassady JM
    Biochem Pharmacol; 1988 Oct; 37(20):3807-16. PubMed ID: 2847745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interconversion of carbamayl-L-aspartate and L-dihydroorotate by dihydroorotase from mouse Ehrlich ascites carcinoma.
    Christopherson RI; Jones ME
    J Biol Chem; 1979 Dec; 254(24):12506-12. PubMed ID: 40997
    [No Abstract]   [Full Text] [Related]  

  • 12. The overall synthesis of L-5,6-dihydroorotate by multienzymatic protein pyr1-3 from hamster cells. Kinetic studies, substrate channeling, and the effects of inhibitors.
    Christopherson RI; Jones ME
    J Biol Chem; 1980 Dec; 255(23):11381-95. PubMed ID: 6108323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of dihydroorotate dehydrogenase in growth cessation of Ehrlich ascites tumor cells cultured under oxygen deficiency.
    Löffler M
    Eur J Biochem; 1980; 107(1):207-15. PubMed ID: 6249586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic inhibitors of the enzymes of the de novo pyrimidine pathway.
    Kensler TW; Cooney DA
    Adv Pharmacol Chemother; 1981; 18():273-352. PubMed ID: 6119898
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic effects of dihydroorotase inhibitors upon human CCRF-CEM leukemia.
    Brooke J; Szabados E; Lyons SD; Goodridge RJ; Harsanyi MC; Poiner A; Christopherson RI
    Cancer Res; 1990 Dec; 50(24):7793-8. PubMed ID: 1979249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess.
    Seymour KK; Yeo AE; Rieckmann KH; Christopherson RI
    Ann Trop Med Parasitol; 1997 Sep; 91(6):603-9. PubMed ID: 9425362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical genetic analysis of pyrimidine biosynthesis in mammalian cells. II. Isolation and characterization of a mutant of Chinese hamster ovary cells with defective dihydroorotate dehydrogenase (E.C. 1.3.3.1) activity.
    Stamato TD; Patterson D
    J Cell Physiol; 1979 Mar; 98(3):459-68. PubMed ID: 220270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genes for and regulation of the enzyme activities of two multifunctional proteins required for the de novo pathway for UMP biosynthesis in mammals.
    Jones ME
    Mol Biol Biochem Biophys; 1980; 32():165-82. PubMed ID: 6108501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mercaptan and dicarboxylate inhibitors of hamster dihydroorotase.
    Christopherson RI; Schmalzl KJ; Szabados E; Goodridge RJ; Harsanyi MC; Sant ME; Algar EM; Anderson JE; Armstrong A; Sharma SC
    Biochemistry; 1989 Jan; 28(2):463-70. PubMed ID: 2565732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multienzymatic proteins in mammalian pyrimidine biosynthesis: channeling of intermediates to avoid futile cycles.
    Christopherson RI; Traut TW; Jones ME
    Curr Top Cell Regul; 1981; 18():59-77. PubMed ID: 7023859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.